SCHEMBL20159752

SCHEMBL20159752

CNc1ccc(C2=NN(c3ccccc3)C(=O)C(C)(C)C2)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.39
PDE4A P27815 2/20 0.38
PDE4B Q07343 2/20 0.38
PDE4C Q08493 2/20 0.38
PDE4D Q08499 2/20 0.38
MEN1 O00255 6/20 0.37
KMT2A Q03164 6/20 0.37
GAA P10253 3/20 0.37
MAPT P10636 3/20 0.37
NPSR1 Q6W5P4 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
KDM4E B2RXH2 2/20 0.36
TDP1 Q9NUW8 2/20 0.36
ALDH1A1 P00352 2/20 0.36
ATM Q13315 1/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM2 P08172 1/20 0.36
CYP3A4 P08684 1/20 0.36
CHRM1 P11229 1/20 0.36
TSHR P16473 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20138653 0.85 GAA (0.48) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL20159211 0.85 SMN1; SMN2 (0.40) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL6014950 0.74 MAPT (0.42) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL4943052 0.68 PDE4B (0.53) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL4944690 0.67 PDE5A (0.53) PDE4APDE4BPDE4CPDE4DMEN1
SCHEMBL4940552 0.66 PDE4B (0.51) PDE4APDE4BPDE4CPDE4DGAA
SCHEMBL4945670 0.66 PDE4B (0.51) PDE4APDE4BPDE4CPDE4DMAOB
SCHEMBL4661656 0.64 CD274 (0.68) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL20142960 0.63 SMN1; SMN2 (0.41) SMN1; SMN2PDE4APDE4BPDE4CPDE4D
SCHEMBL20142920 0.63 CYP19A1 (0.45) SMN1; SMN2MEN1KMT2AMAPTL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018086703-A1 DIHYDROPYRIDAZINONES SUBSTITUTED WITH PHENYLUREAS BAYER PHARMA AKTIENGESELLSCHAFT (DE) 2018-05-17 WO disclosed